Stock Events

Stock Events

Keros Therapeutics (KROS) Q2 2026 Earnings

May 14Confirmed

Q2 2025

Q3 2025

Q4 2025

Q2 2026

-1.21

0.4

2.01

3.62

Details

Expected EPS

-1.022857

Actual EPS

-1.21

Surprise EPS

-0.19

Surprise Percent

-18.3%

Description

⁨Keros Therapeutics⁩ (⁦KROS⁩) has reported earnings of ⁦-1.21⁩ per share for ⁦Q2 2026⁩.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.